Mark Bachleda - 08 Oct 2021 Form 4 Insider Report for Galera Therapeutics, Inc. (GRTX)

Role
Chief Commercial Officer
Signature
/s/ J. Mel Sorensen, Attorney-in-Fact for Mark J. Bachleda
Issuer symbol
GRTX
Transactions as of
08 Oct 2021
Net transactions value
$0
Form type
4
Filing time
12 Oct 2021, 20:23:52 UTC
Next filing
02 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRTX Stock Option (Right to Buy) Award $0 +200,000 $0.000000 200,000 08 Oct 2021 Common Stock 200,000 $7.84 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable as to 25% on October 8, 2022, and in thirty-six (36) substantially equal monthly installments over a three year period thereafter.